Lifecore Biomedical, Inc. Common Stock (LFCR) Stock
NASDAQ · LFCR
4.46
Fundamentals
Market cap
$168.82M
Price / Earnings ratio
-3.9x
Price / Sales ratio
1.3x
Price / Book ratio
-5.0x
Return on assets
N/A
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Lifecore Biomedical, Inc. Common Stock
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees382
CEOMr. Paul Josephs
IPO DateFeb 15, 1996
HeadquartersChaska, MN
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Paul Josephs | President, CEO & Director | 1966 |
| Mr. Ryan D. Lake CPA | Executive VP & CFO | 1977 |
| Mr. Thomas D. Salus | Chief Legal & Administration Officer and Corporate Secretary | 1970 |
| Mr. Thomas Guldager | Senior Vice President of Operations | — |
| Mr. Aaron Perlitsh | Director of Internal Audit & Chief Compliance Officer | — |
| Ms. Jackie Q. Klecker | Executive Vice President of Quality & Development Services | — |
| Mr. Mark DaFonseca | Chief Commercial Officer | — |
| Mr. Parker K. Javid | Vice President | 1969 |
Fundamentals
Valuation
Market cap$168.82M
Price-to-sales ratio1.27
Price-to-book value-4.95
Price-earnings ratio-3.90
Return on EquityN/A
Return on SalesN/A
Return on AssetsN/A
PEG ratio2.66
Earnings Per Share
Earnings Per Share$-1.16
Income Statement
Average volume135,527
EBITDAN/A
1 year high (52w)$8.98
1 year low (52w)$3.63
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



